The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation
Carina Gøtestam SkorpenNational Service for Pregnancy and Rheumatic Diseases, Department of Rheumatology, Trondheim University Hospital, Trondheim, Norway Department of Neuroscience, Norwegian University of Science and Technology (NTNU), Trondheim, Norway Department of Rheumatology, Ålesund Hospital, Ålesund, NorwayMaria HoeltzenbeinBerlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy, Charité-Universitätsmedizin Berlin, Berlin, GermanyAnǵela TincaniDepartment of Clinical and Experimental Science Rheumatology and Clinical Immunology Unit, Spedali Civili and University of Brescia, Brescia, ItalyRebecca Fischer‐BetzDepartment of Rheumatology, University Hospital of Düsseldorf, Duesseldorf, GermanyÉlisabeth ÉléfantCentre de Référence sur les Agents Tératogènes (CRAT), Groupe Hospitalier Universitaire Est, Hôpital Armand Trousseau, Paris, FranceChristina ChambersDepartment of Pediatrics, University of California San Diego, La Jolla, USAJosé António Pereira da SilvaDepartment of Rheumatology, University Hospital, Coimbra, PortugalCatherine Nelson‐PiercyWomen's Health Academic Centre, St Thomas' Hospital, London, UKIrene CetinLuigi Sacco HospitalN. Costedoat‐ChalumeauUniversité Paris-Descartes, Paris, France Service de médecine interne, AP-HP, Hôpital Cochin, Centre de référence maladies auto-immunes et systémiques rares, Paris, FranceRadboud J. E. M. DolhainDepartment of Rheumatology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The NetherlandsFrauke FörgerDepartment of Rheumatology, Immunology and Allergology, University Hospital of Bern, Bern, SwitzerlandMunther A. KhamashtaGraham Hughes Lupus Research Laboratory, Division of Women's Health, King's College London, The Rayne Institute, St Thomas' Hospital, London, UKGuillermo Ruiz‐IrastorzaAutoimmune Diseases Research Unit, Department of Internal Medicine, Biocruces Health Research Institute, University Hospital Cruces, University of the Basque Country, Bizkaia, SpainA. ZinkEpidemiology Unit, and Department for Rheumatology, German Rheumatism Research Centre, Charité University Medicine, Berlin, GermanyJiří VencovskýInstitute of Rheumatology, Praha, Czech RepublicMaurizio CutoloResearch Laboratories and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genova, ItalyN. CaeyersClaudia ZumbühlEULAR Social Leagues Patients' representative, Zürich, SwitzerlandMonika ØstensenNational Service for Pregnancy and Rheumatic Diseases, Department of Rheumatology, Trondheim University Hospital, Trondheim, Norway Department of Neuroscience, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
2016en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0